Northern Light Venture Capital

Founded 2005
Founders Feng Deng Jeffrey Lee Yan Ke


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 242
Average round size
The average size of a deal this fund participated in
Portfolio companies 174
Rounds per year 15.12
Lead investments 46
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 21
Key employees 7
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Internet
  • Software
  • Information Technology
  • Medical
  • Health Care

Northern Light Venture Capital appeared to be the VC, which was created in 2005. The main department of described VC is located in the Beijing. The venture was found in Asia in China.

Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 7-12 investment rounds annually. The typical startup value when the investment from Northern Light Venture Capital is 500 millions - 1 billion dollars. Opposing the other organizations, this Northern Light Venture Capital works on 22 percentage points less the average amount of lead investments.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Dianrong, Vipkid, Among the most popular fund investment industries, there are Health Care, Semiconductor.

The current fund was established by Feng Deng, Yan Ke. The overall number of key employees were 7.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Northern Light Venture Capital, startups are often financed by Sequoia Capital China, Sinovation Ventures, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Matrix Partners China, Sinovation Ventures. In the next rounds fund is usually obtained by IDG Capital, New Enterprise Associates, SAIF Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Northern Light Venture Capital:
Typical Co-investors
Northern Light Venture Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Northern Light Venture Capital:

Funds with similar focus

Funds from China, Beijing
Funds with similar focus located in China, Beijing:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Orient Speech Therapy Center

Language Learning
Speech Recognition
$60M25 Jun 2021 China, " China"}

Nutshell Therapeutics

Health Care
Product Research
$20M15 Jun 2021 China Huangpu Shanghai

Speedaf Express

Freight Service
08 Jun 2021 China, Shenzhen

$100M06 Apr 2021 China Shanghai

Health Care
$73M30 Mar 2021 California Palo Alto United States

MediTrust Health

Health Care
$154M05 Mar 2021 China Minhang District

Teon Therapeutics

$30M23 Feb 2021 California Redwood City United States

Health Care
Medical Device
19 Feb 2021 China Gusu District Jiangsu

Life Science
$61M09 Feb 2021 China Hubei Jiang'an District
New Core Tech Raises USD 35M in Series C Funding

– New Core Tech is a Shanghai, China-based manufacturing company.
– The company raised USD 35M in Series C funding.
– The round was led by XiaoMi, Shunwei Capital with participation from Northern Light Venture Capital and Cowin Capital.
– The new investment will be used to partnership and channel expansion and talent acquisition.

Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors

– Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting immunosuppressive myeloid checkpoints today announced the closing of a $73 million Series B1 and B2 financing.
– The round was led by Oceanpine Capital with participation from additional new investors including Octagon Capital and Sphera Healthcare, and existing investors, including Northern Light Venture Capital and Vivo Capital.
– In conjunction with this round of financing, Oceanpine CEO and managing partner Dave Chenn joins the Immune-Onc Board of Directors.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Northern Light Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: